| human | Q5 |
| P496 | ORCID iD | 0000-0002-2069-7605 |
| P1153 | Scopus author ID | 7005091532 |
| P4789 | Who's Who UK ID | U283384 |
| P512 | academic degree | Doctor of Medicine | Q913404 |
| P27 | country of citizenship | United Kingdom | Q145 |
| P108 | employer | University of Southampton | Q76473 |
| P734 | family name | Primrose | Q37435386 |
| Primrose | Q37435386 | ||
| Primrose | Q37435386 | ||
| P735 | given name | John | Q4925477 |
| John | Q4925477 | ||
| P106 | occupation | surgeon | Q774306 |
| university teacher | Q1622272 | ||
| P21 | sex or gender | male | Q6581097 |
| Q39655711 | A comparison of primary oesophageal squamous epithelial cells with HET-1A in organotypic culture. |
| Q39191297 | A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer. |
| Q44606693 | A randomised clinical trial to assess the effect of total enteral and total parenteral nutritional support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis (APACHE II > or =6). |
| Q36412771 | A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent |
| Q38527867 | A top-down view of the tumor microenvironment: structure, cells and signaling |
| Q92267496 | Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline |
| Q35728465 | Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III |
| Q47918892 | Are the current difficulty scores for laparoscopic liver surgery telling the whole story? An international survey and recommendations for the future |
| Q91057802 | Assessment of Nuclear ZEB2 as a Biomarker for Colorectal Cancer Outcome and TNM Risk Stratification |
| Q47142638 | Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial. |
| Q37236624 | Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1. |
| Q61445664 | Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1 |
| Q44065502 | Body composition, muscle function and psychological changes in patients undergoing operation for hepatic or pancreatic disease. |
| Q44065543 | Body composition, physiological function and psychological changes in patients with predicted severe acute pancreatitis. |
| Q88108875 | CEA monitoring in colorectal cancer is not a waste of time |
| Q35035236 | Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma |
| Q59898446 | Carcinoembryonic Antigen Monitoring to Detect Recurrence of Colorectal Cancer: How Should We Interpret the Test Results? |
| Q53483386 | Cetuximab Is Contraindicated in the Perioperative Treatment of Colorectal Liver Metastases. |
| Q57194976 | Clinician engagement is critical to public engagement with clinical trials |
| Q101166213 | Comment on "Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position" |
| Q92300467 | Development and validation of a model to predict outcomes of colon cancer surveillance |
| Q57191004 | Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence |
| Q38437654 | Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial |
| Q34390509 | Effectiveness of appropriately trained nurses in preoperative assessment: randomised controlled equivalence/non-inferiority trial. |
| Q92731534 | Evaluation and management of incidental gallbladder cancer |
| Q50097202 | Exosomal microRNAs (exomiRs): Small molecules with a big role in cancer |
| Q47239489 | Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression. |
| Q84599852 | Exploring the role of laparoscopic surgery in two-stage hepatectomy for bilobar colorectal liver metastases |
| Q37040688 | FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role. |
| Q42150472 | Guidelines for resection of colorectal cancer liver metastases. |
| Q92596680 | Hepatic Resection Following Selective Internal Radiation Therapy for Colorectal Cancer Metastases in the FOXFIRE Clinical Trial: Clinical Outcomes and Distribution of Microspheres |
| Q47738030 | IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells. |
| Q35904188 | Impact of the introduction of fee for service payments on types of minor surgical procedures undertaken by general practitioners: observational study |
| Q104798160 | Intratumoural immune signature to identify patients with primary colorectal cancer who do not require follow-up after resection: an observational study |
| Q42613885 | Laparoscopic right hepatectomy: a challenging, but feasible, safe and efficient procedure. |
| Q42647160 | Laparoscopic versus open left lateral hepatic sectionectomy: A comparative study. |
| Q64900984 | Lung metastasectomy in colorectal cancer: is this surgery effective in prolonging life? |
| Q56437271 | MTHFR (C677T and A1298C) Polymorphisms and Risk of Sporadic Distal Colorectal Adenoma in the UK Flexible Sigmoidoscopy Screening Trial (United Kingdom) |
| Q37223100 | MicroRNAs: key players in carcinogenesis and novel therapeutic targets. |
| Q45071804 | Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study |
| Q35170178 | Molecular profiling of the invasive tumor microenvironment in a 3-dimensional model of colorectal cancer cells and ex vivo fibroblasts |
| Q92204870 | Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery |
| Q41030531 | Natural killer cell maturation markers in the human liver and expansion of an NKG2C+KIR+ population. |
| Q34455189 | OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. |
| Q38458640 | Oncofetal fibronectin and oral squamous cell carcinoma. |
| Q47660386 | Outcome and Learning Curve in 159 Consecutive Patients Undergoing Total Laparoscopic Hemihepatectomy. |
| Q39585475 | Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study. |
| Q34656647 | Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial |
| Q92291369 | Population-based observational study of acute pancreatitis in southern England |
| Q53388486 | Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). |
| Q39532367 | Propensity score-based analysis of outcomes of laparoscopic versus open liver resection for colorectal metastases |
| Q33398022 | Recognition of skin malignancy by general practitioners: observational study using data from a population-based randomised controlled trial |
| Q56437012 | Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study |
| Q52630948 | Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial. |
| Q34978315 | Short- and long-term outcomes after laparoscopic and open hepatic resection: systematic review and meta-analysis |
| Q42660839 | Short- and medium-term results of totally laparoscopic resection for colorectal liver metastases |
| Q30978235 | Site and Stage of Colorectal Cancer Influence the Likelihood and Distribution of Disease Recurrence and Postrecurrence Survival: Data From the FACS Randomized Controlled Trial |
| Q47788877 | Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. |
| Q45993815 | Spindle cell tumour with glandular elements: an unusual ileal neoplasm. |
| Q35580945 | Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs |
| Q88424870 | Surgeons' assessment versus risk models for predicting complications of hepato-pancreato-biliary surgery (HPB-RISC): a multicenter prospective cohort study |
| Q33834452 | Surgery for colorectal liver metastases. |
| Q84047720 | Surgical management of benign and indeterminate hepatic lesions in the era of laparoscopic liver surgery |
| Q81557372 | Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma |
| Q87965860 | Surveillance for recurrence of colorectal cancer--reply |
| Q28085367 | Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma |
| Q61867795 | Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial |
| Q35119559 | T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases. |
| Q48568425 | The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Indication to Implementation |
| Q38020591 | The adaptive immune response to colorectal cancer: from the laboratory to clinical practice. |
| Q36090214 | The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis |
| Q26852938 | The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation |
| Q39928463 | The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligation. |
| Q36304168 | The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial |
| Q57154574 | The value of tumour debulking for patients with extensive multi-organ metastatic colorectal cancer |
| Q38858806 | Translational aspects in targeting the stromal tumour microenvironment: from bench to bedside. |
| Q36936582 | Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma |
| Q37507336 | Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. |
| Q80495882 | Validation of the lower gastrointestinal electronic referral protocol |
| Q38724626 | What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial |
| Q42921031 | miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance |
Search more.